Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00287391 · ClinicalTrials.gov registry record · Phase 4
Sleep Disorders and Gastroesophageal Reflux Disease (GERD)
A Phase 4 study, sponsored by University of North Carolina.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00287391: Completed Phase 4 study, sponsored by University of North Carolina.
NCT00287391 is a Phase 4 study that has completed, run by University of North Carolina. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00287391, a Phase 4 study, has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will investigate Gastroesophageal Reflux Disease (GERD)as a cause of sleep disturbance. Patients with GERD may experience all or some of the following symptoms: stomach acid or partially digested food re-entering the esophagus (which is sometimes referred to as heartburn or regurgitation) and belching. Even very small, unnoticeable amounts of rising stomach acid may cause patients to wake up during the night. This study will also investigate the effect of Rabeprazole, (brand name Aciphex) on patients with known insomnia. Rabeprazole is an FDA approved medication already marketed for the treatment of GERD.
Interventions
- DRUG Rabeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00287391 record still lists
NCT00287391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Rabeprazole is the first listed.
NCT00287391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00287391 about?
NCT00287391 is a clinical study titled "Sleep Disorders and Gastroesophageal Reflux Disease (GERD)". This study will investigate Gastroesophageal Reflux Disease (GERD)as a cause of sleep disturbance. Patients with GERD may experience all or some of the following symptoms: stomach acid or partially digested food re-entering the esophagus (which is sometimes referred to as heartburn or regurgitation)...
What is the current status of trial NCT00287391?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-09. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00287391?
The interventions under investigation include: Rabeprazole (DRUG).
Who is sponsoring clinical trial NCT00287391?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00287391's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia